LeKrius® Single-Use Freeze-Thaw System

The Drug Substance Freeze-Thaw System, co-developed by LePure Biotech and Haier Biomedical, delivers rapid freeze and thaw in a fully automated, controlled manner. Deployment of single-use technology greatly reduces upfront capital expenditure, raising manufacturing efficiency while lowering overall production costs.

Engineered to satisfy GMP requirements, this freeze-thaw and dispensing system supports freeze-thaw processing for liquids including antibodies, cell and gene therapies, vaccines and blood products. Integrating freezing and thawing within one platform and adopting a controlled freeze-thaw regime, it creates a controlled, reproducible and robust thermal environment for liquid bioproducts, especially biomolecule intermediates. The controlled freeze-thaw system reduces microbial contamination risk and effectively extends product shelf life while safeguarding product quality and stability.

Request A Quote

By clicking the Submit button, you acknowledge that you have read and agree to the Privacy Policy.

Privacy Policy Consent